BPC 157: Miracle Healing Peptide or Hidden Danger? Deep Dive: Regulatory Status of Popular Compounded Peptides Holt Law The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York FDA moves toward easing restrictions on certain peptides BioPharma Dive Injectable Peptides: Out of the Back Alley and Into the Light? Berkley Lifesciences